FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to ophthalmology, and can be used for early diagnosis of meibomian gland dysfunction (MGD) in type 2 diabetes mellitus. That is ensured by laser Doppler flowmetry. If the neurogenic oscillations decrease by 15.41% and more relative to the neurogenic oscillation index in the patients with MGD without diabetes mellitus of 4.8%, meibomian gland dysfunction is diagnosed in type 2 diabetes mellitus.
EFFECT: invention provides the possibility of detecting early signs of MGD in patients with type 2 diabetes mellitus for timely selection of pathogenetically oriented therapy.
1 cl, 2 ex, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR EVALUATION OF EFFICIENCY OF TREATMENT OF CHRONIC BLEPHARITIS BY LASER DOPPLER FLOWMETRY | 2017 |
|
RU2644699C1 |
| METHOD FOR ASSESSING MORPHOFUNCTIONAL STATUS OF MEIBOMIAN GLANDS - MEIBOMIAN GLANDS BIOMETRY | 2014 |
|
RU2567829C1 |
| METHOD OF DETERMINING DEGREE OF BLEPHAROCONJUNCTIVAL FORM OF DRY EYE SYNDROME | 2012 |
|
RU2500340C1 |
| METHOD FOR COMPLEX THERAPY OF DYSFUNCTION OF THE MEIBOMIAN GLANDS | 2022 |
|
RU2790805C1 |
| METHOD OF TREATING BLEPHAROCONJUNCTIVAL FORM OF DRY EYE SYNDROME | 2012 |
|
RU2510701C1 |
| METHOD OF DETERMINING FUNCTIONAL STATE OF TARSAL GLANDS | 2008 |
|
RU2373832C1 |
| METHOD FOR TREATING BLEPHAROCONJUNCTIVAL DRY EYE SYNDROME FORM CASES | 2006 |
|
RU2312640C1 |
| METHOD FOR CARRYING OUT COMBINED TREATMENT OF MEIBOMIAN GLANDS DYSFUNCTION CASES | 2006 |
|
RU2314102C1 |
| METHOD OF TREATING PERIPHERAL ULCERATIVE KERATITIS ACCOMPANYING SJOGREN'S SYNDROME ASSOCIATED WITH RHEUMATOID ARTHRITIS | 2015 |
|
RU2585611C1 |
| METHOD OF TREATING INFLAMMATIONS OF ANTERIOR EYE SEGMENT | 2013 |
|
RU2513597C1 |
